Sample summary
| Group . | Unique firms . | Firm-years . | Pre-IPO . | Post-IPO . |
|---|---|---|---|---|
| Treatment | 827 | 4750 | 2182 | 2568 |
| Control | 258 | 1020 | 1020 | 0 |
| Full sample | 1085 | 5770 | 3202 | 2568 |
| Group . | Unique firms . | Firm-years . | Pre-IPO . | Post-IPO . |
|---|---|---|---|---|
| Treatment | 827 | 4750 | 2182 | 2568 |
| Control | 258 | 1020 | 1020 | 0 |
| Full sample | 1085 | 5770 | 3202 | 2568 |
Note(s): This table provides a sample summary. The treatment (control) group comprises 4,750 (1,020) firm-year observations from 827 (258) unique firms